筛查标准修改对肺癌筛查资格中种族和性别差异的潜在影响
利用肺结节项目数据,比较USPSTF2013、USPSTF2021及放宽戒烟年限和吸烟包年数的修改标准对低剂量CT筛查资格和肺癌检出的人群构成影响。放宽标准使更多女性和黑人获得筛查资格,并使肺癌患者总数增加37%。
要点
- 放宽戒烟年限至≤25年和吸烟包年数至≥10年后,符合筛查资格者比例从USPSTF2013的13%升至21%。
- 新增合格者中黑人比例在USPSTF2021为27%、联合修改标准为29%,均高于USPSTF2013的17%(p<0.0001)。
- 联合修改标准使肺癌患者总数增加37%,新增肺癌患者中女性占57%(USPSTF2013为48%,p=0.0476)。
核心结论
- 放宽低剂量CT筛查资格标准(延长戒烟年限和减少吸烟包年数)可使筛查合格人群中女性和黑人比例增加。
研究设计与样本
- 利用肺结节项目数据,比较五种筛查标准下低剂量CT筛查资格和肺癌检出情况,采用卡方检验或方差分析进行组间比较。
主要发现
- 共分析17,421人,女性占56%,白人占69%,黑人占28%;符合USPSTF2013、USPSTF2021、USPSTF2021-QD25、USPSTF2021-PY10和USPSTF2021-QD25-PY10标准者分别占13%、17%、18%、19%和21%。
- USPSTF2021新增合格者(n=682)中黑人占27%,USPSTF2021-QD25-PY10新增合格者(n=1402)中黑人占29%,均显著高于USPSTF2013的17%(p<0.0001)。
- 新增合格者中女性比例在USPSTF2021为55%、USPSTF2021-QD25-PY10为55%,均高于USPSTF2013的48%(p<0.05)。
- 1243例(7.1%)肺癌患者中,22%符合USPSTF2013筛查标准;USPSTF2021-QD25-PY10使肺癌患者总数增加37%。
- 新增肺癌患者中女性占57%(USPSTF2013为48%,p=0.0476),黑人占24%(USPSTF2013为20%,p=0.3367)。
关键数值与推荐
- USPSTF2013标准:55-80岁,吸烟≥30包年,戒烟≤15年。
- USPSTF2021标准:50-80岁,吸烟≥20包年,戒烟≤15年。
- USPSTF2021-QD25:在USPSTF2021基础上戒烟年限扩展至≤25年。
- USPSTF2021-PY10:在USPSTF2021基础上吸烟包年数降至≥10包年。
- USPSTF2021-QD25-PY10:同时采用上述两项修改。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Low-dose computed tomography (LDCT) screening reduces lung cancer mortality, but current eligibility criteria underestimate risk in women and racial minorities. We evaluated the impact of screening criteria modifications on LDCT eligibility and lung cancer detection. METHODS: Using data from a Lung Nodule Program, we compared persons eligible for LDCT by the following: U.S. Preventive Services Task Force (USPSTF) 2013 criteria (55-80 y, ≥30 pack-years of smoking, and ≤15 y since cessation); USPSTF2021 criteria (50-80 y, ≥20 pack-years of smoking, and ≤15 y since cessation); quit duration expanded to less than or equal to 25 years (USPSTF2021-QD25); reducing the pack-years of smoking to more than or equal to 10 years (USPSTF2021-PY10); and both (USPSTF2021-QD25-PY10). We compare across groups using the chi-square test or analysis of variance. RESULTS: The 17,421 individuals analyzed were of 56% female sex, 69% white, 28% black; 13% met USPSTF2013 criteria; 17% USPSTF2021; 18% USPSTF2021-QD25; 19% USPSTF2021-PY10; and 21% USPSTF2021-QD25-PY10. Additional eligible individuals by USPSTF2021 (n = 682) and USPSTF2021-QD25-PY10 (n = 1402) were 27% and 29% black, both significantly higher than USPSTF2013 (17%, p < 0.0001). These additional eligible individuals were 55% (USPSTF2021) and 55% (USPSTF2021-QD25-PY10) of female sex, compared with 48% by USPSTF2013 (p < 0.05). Of 1243 persons (7.1%) with lung cancer, 22% were screening eligible by USPSTF13. USPSTF2021-QD25-PY10 increased the total number of persons with lung cancer by 37%. These additional individuals with lung cancer were of 57% female sex (versus 48% with USPSTF2013, p = 0.0476) and 24% black (versus 20% with USPSTF2013, p = 0.3367). CONCLUSIONS: Expansion of LDCT screening eligibility criteria to allow longer quit duration and fewer pack-years of exposure enriches the screening-eligible population for women and black persons.
引用
- Smeltzer MP, Liao W, Faris NR, et al. Potential Impact of Criteria Modifications on Race and Sex Disparities in Eligibility for Lung Cancer Screening. J Thorac Oncol. 2022. PMID: 36208717. doi:10.1016/j.jtho.2022.09.220
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。